Skip to main content
OpenTrials
Completed

NCT Number: NCT00863564

Acute Effects of Dietary Proteins on Postprandial Lipemia, Incretin Responses and Subclinical Inflammation in Obese Subjects

The purpose of this study is to determine the effects of dietary protein on blood lipids and gut hormones after a fat-rich meal.

Hypothesis: Certain dietary proteins reduce the amount of fat circulating in the blood stream following a fat rich meal. The effect is dependant of both the quality and the quantity of protein ingested.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • BMI > 30 kg/m2 & < 45 kg/m2

Exclusion criteria

  • Diabetes
  • Lipid lowering drugs
  • Liver-, Kidney- and/or Heart Disease
  • Serious Hypertension (160/110)

Treatment and study plan

Caseine

Dietary Supplement

Cod

Dietary Supplement

gluten

Dietary Supplement

Whey Isolate

Dietary Supplement

Primary outcomes

  1. Triglyceride

    Time frame: 0h- 2h- 4h- 6h- 8h postprandial

Secondary outcomes

  1. Incretins

    Time frame: 0h -1h -2h -4h -6h -8h Postprandial

  2. Inflammatory markers

    Time frame: 0h- 1h- 2h- 4h- 6h- 8h postprandial

Sponsors and collaborators

Lead sponsor

Aarhus University Hospital

Other

Collaborators

  • Nordic Centre of Excellence
  • The Danish Obesity Research Centre

Registry information

Important dates

Study start
2009
Primary completion
2009
Study completion
2009
First posted
Mar 18, 2009
Registry last updated
Nov 10, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.